comparemela.com

Latest Breaking News On - Gulf pharmaceutical - Page 1 : comparemela.com

Julphar H1 2023 revenues surge to Dhs859 4m on solid growth

Home-Use Insulin Delivery Devices Market to Hit $19,087 6 Million Revenue by 2030 says P&S Intelligence

One Dubai F&B company continues its glory run as investors favourite

But the star is. Emirates Refreshments Company, which has seen a breathtaking 247 per cent climb. In late October, a Canadian engineering company had acquired around 9 per cent stake in it. More importantly, the F&B entity raised its authorised capital to Dh600 million, while the issued share capital increased from Dh270 million to Dh300 million through a rights issue. The company plans to expand its activities to real estate investments, construction and facility management, industrial and mining activities, and healthcare. Reflecting the new profile, the firm will change the name to Emirates Reem Investment Company . Nevertheless, it s worth noting the shares have run up quite a bit and the current market cap of Dh536 million is much more than the proposed paid-up capital of Dh300 million. The authorised capital is not a useful metric as there is no assurance it will raise the capital.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.